Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Evolus price target lowered to $7 from $8 at Barclays » 06:31
05/13/21
05/13
06:31
05/13/21
06:31
EOLS

Evolus

/

+

Barclays analyst Balaji…

Barclays analyst Balaji Prasad lowered the firm's price target on Evolus to $7 from $8 and keeps an Underweight rating on the shares post the Q1 results. The analyst tweaked his revenue and cash flow forecasts lower but says a "cleaner business is emerging" with no legal distractions and sufficient capital post the recent equity rise.

ShowHide Related Items >><<
EOLS Evolus
/

+

EOLS Evolus
/

+

05/06/21 Mizuho
Evolus upgraded to Buy from Neutral at Mizuho
04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
EOLS Evolus
/

+

  • 22
    Apr
EOLS Evolus
/

+

EOLS Evolus
/

+

EOLS Evolus
/

+

Yesterday
Hot Stocks
Evolus' Jeuveau on track for $100M annual net revenue run rate in Q2 » 16:25
05/12/21
05/12
16:25
05/12/21
16:25
EOLS

Evolus

$8.40 /

-0.34 (-3.89%)

"We believe Jeuveau…

"We believe Jeuveau is on track to achieve an annualized net revenue run rate of $100M in the second quarter of 2021," said Evolus CEO David Moatazedi.

ShowHide Related Items >><<
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

05/06/21 Mizuho
Evolus upgraded to Buy from Neutral at Mizuho
04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

  • 22
    Apr
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

Earnings
Evolus reports Q1 diluted EPS 16c, may not compare to consensus (43c) » 16:24
05/12/21
05/12
16:24
05/12/21
16:24
EOLS

Evolus

$8.40 /

-0.34 (-3.89%)

Reports Q1 revenue…

Reports Q1 revenue $12.2M, consensus $11.67M.

ShowHide Related Items >><<
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

05/06/21 Mizuho
Evolus upgraded to Buy from Neutral at Mizuho
04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

  • 22
    Apr
EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

EOLS Evolus
$8.40 /

-0.34 (-3.89%)

Hot Stocks
Evolus announces two published studies on safety, efficacy of Jeuveau » 09:05
05/12/21
05/12
09:05
05/12/21
09:05
EOLS

Evolus

$8.74 /

-0.13 (-1.47%)

Evolus announced two…

Evolus announced two newly published peer review studies in Aesthetic Surgery Journal that provide supportive evidence of the safety and efficacy of repeat doses of prabotulinumtoxinA to decrease the appearance of glabellar lines, also known as frown lines between the eyes. The two Phase II studies, conducted to support the registration and regulatory approval of Jeuveau in the United States, Canada and Europe, demonstrate that prolonged use of Jeuveau is safe and effective with repeat treatments. The studies also reveal that the patented Hi-Pure manufacturing technology used to make Jeuveau is not associated with antibody formation or neutralizing antibody formation. Both studies were long-term, open-label, phase II studies designed to investigate the safety of repeat doses of 20 U prabotulinumtoxinA for the treatment of glabellar lines. The complementary studies primarily differed in the number of patients and in the product formulation process employed. In both studies, among study completers, there was no evidence of shortening retreatment periods that might suggest immunogenicity and/or the development of resistance; in fact, the opposite was observed, with a trend towards longer retreatment periods. This is important because, when treating patients with a biological agent, a shortening time interval between treatments may be suggestive of increasing resistance or antibody development. In addition, the percentage of patients who experienced an adverse event after treatment decreased with repeat exposure. The most reported AE was headache. There were no serious adverse reactions related to the drug. Jeuveau is marketed in the United States by Evolus. The product is marketed by a partner in Canada as Nuceiva with European launch planned for early 2022.

ShowHide Related Items >><<
EOLS Evolus
$8.74 /

-0.13 (-1.47%)

EOLS Evolus
$8.74 /

-0.13 (-1.47%)

05/06/21 Mizuho
Evolus upgraded to Buy from Neutral at Mizuho
04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
EOLS Evolus
$8.74 /

-0.13 (-1.47%)

  • 22
    Apr
EOLS Evolus
$8.74 /

-0.13 (-1.47%)

EOLS Evolus
$8.74 /

-0.13 (-1.47%)

EOLS Evolus
$8.74 /

-0.13 (-1.47%)

Over a week ago
Upgrade
Evolus upgraded to Buy from Neutral at Mizuho » 06:00
05/06/21
05/06
06:00
05/06/21
06:00
EOLS

Evolus

$8.88 /

-0.125 (-1.39%)

Mizuho analyst Vamil…

Mizuho analyst Vamil Divan upgraded Evolus to Buy from Neutral with an unchanged price target of $15. Following the recent weakness in the shares, the company's risk/reward is attractive ahead of the Q1 earnings report on May 12, Divan tells investors in a research note. Evolus is relaunching Jeuveau, "free from the cloud" of the International Trade Commission overhang, into an aesthetics market that is rapidly recovering from the impact of the COVID-19 pandemic, the analyst says. Divan sees 69% upside from current share levels.

ShowHide Related Items >><<
EOLS Evolus
$8.88 /

-0.125 (-1.39%)

EOLS Evolus
$8.88 /

-0.125 (-1.39%)

04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
EOLS Evolus
$8.88 /

-0.125 (-1.39%)

  • 22
    Apr
EOLS Evolus
$8.88 /

-0.125 (-1.39%)

EOLS Evolus
$8.88 /

-0.125 (-1.39%)

EOLS Evolus
$8.88 /

-0.125 (-1.39%)

On The Fly
Fly Intel: Pre-market Movers » 08:54
04/22/21
04/22
08:54
04/22/21
08:54
RNLX

Renalytix AI

$25.26 /

-0.445 (-1.73%)

, SKLZ

Skillz

$16.75 /

+4.215 (+33.63%)

, T

AT&T

$30.11 /

+0.23 (+0.77%)

, BX

Blackstone

$80.33 /

+0.84 (+1.06%)

, HCA

HCA Healthcare

$197.43 /

+4.5 (+2.33%)

, LUV

Southwest

$62.04 /

+2.19 (+3.66%)

, DHI

D.R. Horton

$93.34 /

+1.37 (+1.49%)

, TSCO

Tractor Supply

$180.30 /

-0.93 (-0.51%)

, DGX

Quest Diagnostics

$130.08 /

+0.79 (+0.61%)

, HBAN

Huntington Bancshares

$15.50 /

+0.33 (+2.18%)

, AAL

American Airlines

$21.00 /

+0.64 (+3.14%)

, ALKS

Alkermes

$20.49 /

+0.33 (+1.64%)

, HIG

Hartford Financial

$67.45 /

+1.7 (+2.59%)

, EOLS

Evolus

$11.69 /

+1.16 (+11.02%)

, FSR

Fisker

$15.15 /

+2.22 (+17.17%)

, NBSE

NeuBase Therapeutics

$6.01 /

+0.19 (+3.26%)

, RIDE

Lordstown Motors

$9.76 /

+0.58 (+6.32%)

Check out this morning's…

ShowHide Related Items >><<
TSCO Tractor Supply
$180.30 /

-0.93 (-0.51%)

T AT&T
$30.11 /

+0.23 (+0.77%)

SKLZ Skillz
$16.75 /

+4.215 (+33.63%)

RNLX Renalytix AI
$25.26 /

-0.445 (-1.73%)

RIDE Lordstown Motors
$9.76 /

+0.58 (+6.32%)

NBSE NeuBase Therapeutics
$6.01 /

+0.19 (+3.26%)

LUV Southwest
$62.04 /

+2.19 (+3.66%)

HIG Hartford Financial
$67.45 /

+1.7 (+2.59%)

HCA HCA Healthcare
$197.43 /

+4.5 (+2.33%)

HBAN Huntington Bancshares
$15.50 /

+0.33 (+2.18%)

FSR Fisker
$15.15 /

+2.22 (+17.17%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

DHI D.R. Horton
$93.34 /

+1.37 (+1.49%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

BX Blackstone
$80.33 /

+0.84 (+1.06%)

ALKS Alkermes
$20.49 /

+0.33 (+1.64%)

AAL American Airlines
$21.00 /

+0.64 (+3.14%)

RNLX Renalytix AI
$25.26 /

-0.445 (-1.73%)

04/22/21 Investec
Renalytix AI upgraded to Buy from Hold at Investec
04/08/21 Stifel
Renalytix presented survey suggests favorable view on KidneyIntelX, says Stifel
03/02/21 Investec
Renalytix AI downgraded to Hold from Buy at Investec
01/12/21 Stifel
Renalytix AI, Exact Sciences may benefit from final MCIT rule, says Stifel
SKLZ Skillz
$16.75 /

+4.215 (+33.63%)

03/25/21 Stifel
Skillz price target lowered to $28 from $30 at Stifel
03/11/21 Canaccord
Skillz price target raised to $33 from $32 at Canaccord
02/25/21
Fly Intel: Top five analyst initiations
02/25/21 UBS
Skillz initiated with a Neutral at UBS
T AT&T
$30.11 /

+0.23 (+0.77%)

03/10/21 RBC Capital
Fortinet price target raised to $175 from $162 at RBC Capital
03/10/21 DA Davidson
Fortinet price target raised to $200 from $180 at DA Davidson
03/10/21 BTIG
Fortinet price target raised to $205 from $183 at BTIG
03/05/21 JPMorgan
JPMorgan sees AT&T rallying into analyst meeting, but not after
BX Blackstone
$80.33 /

+0.84 (+1.06%)

04/12/21 Barclays
Blackstone price target raised to $85 from $75 at Barclays
04/09/21 Deutsche Bank
Blackstone price target raised to $66 from $61 at Deutsche Bank
03/19/21
Fly Intel: Top five analyst downgrades
03/18/21 Oppenheimer
Blackstone downgraded to Perform on valuation at Oppenheimer
HCA HCA Healthcare
$197.43 /

+4.5 (+2.33%)

04/14/21 Truist
HCA Healthcare price target raised to $230 from $200 at Truist
04/13/21 Deutsche Bank
HCA Healthcare price target raised to $210 from $180 at Deutsche Bank
04/09/21 Mizuho
HCA Healthcare price target raised to $205 from $195 at Mizuho
02/05/21 Mizuho
HCA Healthcare price target raised to $195 from $180 at Mizuho
LUV Southwest
$62.04 /

+2.19 (+3.66%)

04/15/21 Barclays
Southwest price target raised to $64 from $51 at Barclays
04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 JPMorgan
Southwest upgraded to Neutral from Underweight at JPMorgan
04/12/21 Raymond James
Southwest price target raised to $71 from $54 at Raymond James
DHI D.R. Horton
$93.34 /

+1.37 (+1.49%)

04/21/21 Barclays
D.R. Horton price target raised to $108 from $95 at Barclays
04/15/21 Wells Fargo
D.R. Horton initiated with an Overweight at Wells Fargo
04/07/21 JPMorgan
JPMorgan lays out long and short homebuilding ideas into earnings
03/16/21 Wolfe Research
D.R. Horton initiated with Outperform, $94 target at Wolfe Research
TSCO Tractor Supply
$180.30 /

-0.93 (-0.51%)

04/19/21 Baird
Tractor Supply price target raised to $200 from $180 at Baird
04/19/21 Wedbush
Tractor Supply price target raised to $180 from $145 at Wedbush
04/19/21 Piper Sandler
Tractor Supply price target raised to $203 from $175 at Piper Sandler
04/07/21 Guggenheim
Tractor Supply price target raised to $200 from $180 at Guggenheim
DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
HBAN Huntington Bancshares
$15.50 /

+0.33 (+2.18%)

04/07/21 Barclays
Huntington Bancshares price target raised to $17 from $15 at Barclays
04/01/21 Deutsche Bank
Huntington Bancshares price target raised to $16 from $14 at Deutsche Bank
03/30/21 Stephens
Huntington Bancshares price target raised to $17.50 from $14 at Stephens
01/25/21 Baird
Huntington Bancshares weakness buying opportunity, says Baird
AAL American Airlines
$21.00 /

+0.64 (+3.14%)

04/15/21 Barclays
American Airlines price target raised to $18 from $11 at Barclays
04/06/21 Morgan Stanley
American Airlines initiated with an Underweight at Morgan Stanley
03/30/21
Fly Intel: Top five analyst upgrades
03/30/21 Jefferies
Jefferies upgrades American Airlines to Hold on outperformance potential
ALKS Alkermes
$20.49 /

+0.33 (+1.64%)

04/08/21 H.C. Wainwright
Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
04/07/21 Mizuho
Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
03/01/21
Fly Intel: Top five analyst initiations
03/01/21 Jefferies
Alkermes assumed with a Hold at Jefferies
HIG Hartford Financial
$67.45 /

+1.7 (+2.59%)

04/12/21 JPMorgan
Hartford Financial price target raised to $75 from $55 at JPMorgan
04/05/21 Raymond James
Hartford Financial price target raised to $75 from $65 at Raymond James
03/31/21 Citi
Hartford Financial price target raised to $67 from $54 at Citi
03/30/21 RBC Capital
Hartford Financial price target raised to $67 from $51 at RBC Capital
EOLS Evolus
$11.69 /

+1.16 (+11.02%)

04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
FSR Fisker
$15.15 /

+2.22 (+17.17%)

04/22/21 Goldman Sachs
Fisker downgraded to Sell from Neutral at Goldman Sachs
04/20/21 Morgan Stanley
Fisker remains 'top ranked' EV related SPAC startup, says Morgan Stanley
04/20/21 BofA
Fisker initiated with a Buy at BofA
04/20/21 BofA
Fisker initiated with a Buy at BofA
NBSE NeuBase Therapeutics
$6.01 /

+0.19 (+3.26%)

02/12/21 H.C. Wainwright
NeuBase Therapeutics price target raised to $18 from $15 at H.C. Wainwright
06/16/20 RBC Capital
NeuBase Therapeutics initiated with an Outperform at RBC Capital
RIDE Lordstown Motors
$9.76 /

+0.58 (+6.32%)

04/22/21 Goldman Sachs
Lordstown Motors downgraded to Neutral from Buy at Goldman Sachs
04/20/21 BofA
Lordstown Motors initiated with a Neutral at BofA
04/20/21 BofA
Lordstown Motors initiated with a Neutral at BofA
03/18/21 Morgan Stanley
Lordstown Motors price target lowered to $12 from $18 at Morgan Stanley
TSCO Tractor Supply
$180.30 /

-0.93 (-0.51%)

T AT&T
$30.11 /

+0.23 (+0.77%)

SKLZ Skillz
$16.75 /

+4.215 (+33.63%)

RNLX Renalytix AI
$25.26 /

-0.445 (-1.73%)

RIDE Lordstown Motors
$9.76 /

+0.58 (+6.32%)

NBSE NeuBase Therapeutics
$6.01 /

+0.19 (+3.26%)

LUV Southwest
$62.04 /

+2.19 (+3.66%)

HIG Hartford Financial
$67.45 /

+1.7 (+2.59%)

HCA HCA Healthcare
$197.43 /

+4.5 (+2.33%)

HBAN Huntington Bancshares
$15.50 /

+0.33 (+2.18%)

FSR Fisker
$15.15 /

+2.22 (+17.17%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

DHI D.R. Horton
$93.34 /

+1.37 (+1.49%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

BX Blackstone
$80.33 /

+0.84 (+1.06%)

ALKS Alkermes
$20.49 /

+0.33 (+1.64%)

AAL American Airlines
$21.00 /

+0.64 (+3.14%)

  • 22
    Apr
  • 22
    Apr
  • 19
    Mar
  • 10
    Nov
  • 17
    Jul
  • 23
    Jun
  • 29
    Apr
  • 28
    Apr
T AT&T
$30.11 /

+0.23 (+0.77%)

SKLZ Skillz
$16.75 /

+4.215 (+33.63%)

RIDE Lordstown Motors
$9.76 /

+0.58 (+6.32%)

LUV Southwest
$62.04 /

+2.19 (+3.66%)

HIG Hartford Financial
$67.45 /

+1.7 (+2.59%)

HCA HCA Healthcare
$197.43 /

+4.5 (+2.33%)

HBAN Huntington Bancshares
$15.50 /

+0.33 (+2.18%)

FSR Fisker
$15.15 /

+2.22 (+17.17%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

DHI D.R. Horton
$93.34 /

+1.37 (+1.49%)

BX Blackstone
$80.33 /

+0.84 (+1.06%)

ALKS Alkermes
$20.49 /

+0.33 (+1.64%)

AAL American Airlines
$21.00 /

+0.64 (+3.14%)

TSCO Tractor Supply
$180.30 /

-0.93 (-0.51%)

T AT&T
$30.11 /

+0.23 (+0.77%)

SKLZ Skillz
$16.75 /

+4.215 (+33.63%)

RIDE Lordstown Motors
$9.76 /

+0.58 (+6.32%)

NBSE NeuBase Therapeutics
$6.01 /

+0.19 (+3.26%)

LUV Southwest
$62.04 /

+2.19 (+3.66%)

HIG Hartford Financial
$67.45 /

+1.7 (+2.59%)

HCA HCA Healthcare
$197.43 /

+4.5 (+2.33%)

HBAN Huntington Bancshares
$15.50 /

+0.33 (+2.18%)

FSR Fisker
$15.15 /

+2.22 (+17.17%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

DHI D.R. Horton
$93.34 /

+1.37 (+1.49%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

BX Blackstone
$80.33 /

+0.84 (+1.06%)

ALKS Alkermes
$20.49 /

+0.33 (+1.64%)

AAL American Airlines
$21.00 /

+0.64 (+3.14%)

TSCO Tractor Supply
$180.30 /

-0.93 (-0.51%)

T AT&T
$30.11 /

+0.23 (+0.77%)

SKLZ Skillz
$16.75 /

+4.215 (+33.63%)

RNLX Renalytix AI
$25.26 /

-0.445 (-1.73%)

RIDE Lordstown Motors
$9.76 /

+0.58 (+6.32%)

LUV Southwest
$62.04 /

+2.19 (+3.66%)

HBAN Huntington Bancshares
$15.50 /

+0.33 (+2.18%)

FSR Fisker
$15.15 /

+2.22 (+17.17%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

DHI D.R. Horton
$93.34 /

+1.37 (+1.49%)

DGX Quest Diagnostics
$130.08 /

+0.79 (+0.61%)

BX Blackstone
$80.33 /

+0.84 (+1.06%)

AAL American Airlines
$21.00 /

+0.64 (+3.14%)

Syndicate
Evolus 9M share Spot Secondary priced at $9.50 » 06:20
04/22/21
04/22
06:20
04/22/21
06:20
EOLS

Evolus

$11.69 /

+1.16 (+11.02%)

The deal range was…

The deal range was $9.50-$10.00. SVB Leerink, Stifel and Cantor Fitzgerald acted as joint book running managers for the offering.

ShowHide Related Items >><<
EOLS Evolus
$11.69 /

+1.16 (+11.02%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
EOLS Evolus
$11.69 /

+1.16 (+11.02%)

  • 22
    Apr
EOLS Evolus
$11.69 /

+1.16 (+11.02%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

On The Fly
Fly Intel: After-Hours Movers » 18:51
04/21/21
04/21
18:51
04/21/21
18:51
NBSE

NeuBase Therapeutics

$6.01 /

+0.19 (+3.26%)

, EOLS

Evolus

$11.69 /

+1.16 (+11.02%)

, SEIC

SEI Investments

$63.04 /

+0.3 (+0.48%)

, CACI

CACI

$255.88 /

-6 (-2.29%)

, NTGR

Netgear

$37.81 /

+0.31 (+0.83%)

, SNBR

Sleep Number

$124.88 /

+5.07 (+4.23%)

, TDC

Teradata

$39.89 /

+1.07 (+2.76%)

, CMG

Chipotle

$1,507.85 /

-25.58 (-1.67%)

, WHR

Whirlpool

$234.84 /

-1.63 (-0.69%)

, SAVE

Spirit Airlines

$36.04 /

+1.36 (+3.92%)

, CP

Canadian Pacific

$355.40 /

+0.55 (+0.15%)

, KMI

Kinder Morgan

$16.70 /

+0.15 (+0.91%)

, DFS

Discover

$98.44 /

+1.59 (+1.64%)

, SLM

Sallie Mae

$19.55 /

+0.78 (+4.16%)

, CLB

Core Laboratories

$27.05 /

+0.79 (+3.01%)

, UFPI

UFP Industries

$78.18 /

+0.77 (+0.99%)

, RHI

Robert Half

$82.61 /

+1.235 (+1.52%)

, CHDN

Churchill Downs

$219.10 /

+8.16 (+3.87%)

, STC

Stewart

$56.38 /

+0.21 (+0.37%)

, EFX

Equifax

$192.59 /

+0.355 (+0.18%)

, XM

Qualtrics

$33.80 /

+ (+0.00%)

ShowHide Related Items >><<
XM Qualtrics
$33.80 /

+ (+0.00%)

WHR Whirlpool
$234.84 /

-1.63 (-0.69%)

UFPI UFP Industries
$78.18 /

+0.77 (+0.99%)

TDC Teradata
$39.89 /

+1.07 (+2.76%)

STC Stewart
$56.38 /

+0.21 (+0.37%)

SNBR Sleep Number
$124.88 /

+5.07 (+4.23%)

SLM Sallie Mae
$19.55 /

+0.78 (+4.16%)

SEIC SEI Investments
$63.04 /

+0.3 (+0.48%)

SAVE Spirit Airlines
$36.04 /

+1.36 (+3.92%)

RHI Robert Half
$82.61 /

+1.235 (+1.52%)

NBSE NeuBase Therapeutics
$6.01 /

+0.19 (+3.26%)

KMI Kinder Morgan
$16.70 /

+0.15 (+0.91%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

EFX Equifax
$192.59 /

+0.355 (+0.18%)

DFS Discover
$98.44 /

+1.59 (+1.64%)

CP Canadian Pacific
$355.40 /

+0.55 (+0.15%)

CMG Chipotle
$1,507.85 /

-25.58 (-1.67%)

CLB Core Laboratories
$27.05 /

+0.79 (+3.01%)

CHDN Churchill Downs
$219.10 /

+8.16 (+3.87%)

CACI CACI
$255.88 /

-6 (-2.29%)

NBSE NeuBase Therapeutics
$6.01 /

+0.19 (+3.26%)

02/12/21 H.C. Wainwright
NeuBase Therapeutics price target raised to $18 from $15 at H.C. Wainwright
06/16/20 RBC Capital
NeuBase Therapeutics initiated with an Outperform at RBC Capital
EOLS Evolus
$11.69 /

+1.16 (+11.02%)

04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
SEIC SEI Investments
$63.04 /

+0.3 (+0.48%)

01/06/21 Goldman Sachs
SEI Investments initiated with a Buy at Goldman Sachs
11/30/20 Morgan Stanley
Morgan Stanley upgrades Large Cap Banks & Consumer Finance to Attractive
11/30/20 Morgan Stanley
SEI Investments downgraded to Equal Weight at Morgan Stanley
11/30/20 Morgan Stanley
SEI Investments downgraded to Equal Weight from Overweight at Morgan Stanley
CACI CACI
$255.88 /

-6 (-2.29%)

03/26/21 Stifel
Stifel downgrades SAIC to Hold after 'materially reset' expectations
02/23/21 William Blair
William Blair reiterates Outperform on Leidos following quarterly results
01/29/21 Truist
CACI price target raised to $290 from $275 at Truist
01/27/21 Stifel
CACI 'very likely' to bid on Perspecta as well, says Stifel
NTGR Netgear
$37.81 /

+0.31 (+0.83%)

02/04/21 BWS Financial
Netgear price target raised to $58 from $45 at BWS Financial
02/04/21 Deutsche Bank
Netgear price target raised to $44 from $40 at Deutsche Bank
10/22/20 Cowen
Netgear price target raised to $43 from $35 at Cowen
10/22/20 Deutsche Bank
Netgear price target raised to $39 from $32 at Deutsche Bank
SNBR Sleep Number
$124.88 /

+5.07 (+4.23%)

02/18/21
Fly Intel: Top five analyst upgrades
02/18/21 Wedbush
Sleep Number price target raised to $130 from $120 at Wedbush
02/18/21 Piper Sandler
Sleep Number price target raised to $165 from $108 at Piper Sandler
02/18/21 UBS
Sleep Number upgraded to Neutral from Sell at UBS
TDC Teradata
$39.89 /

+1.07 (+2.76%)

04/08/21 Morgan Stanley
Teradata price target raised to $45 from $44 at Morgan Stanley
02/08/21 JMP Securities
Teradata upgraded to Outperform from Market Perform at JMP Securities
02/08/21 JMP Securities
Teradata upgraded to Outperform from Market Perform at JMP Securities
02/05/21 Citi
Teradata price target raised to $36 from $32 at Citi
CMG Chipotle
$1,507.85 /

-25.58 (-1.67%)

04/19/21 Stifel
Chipotle price target raised to $1,750 from $1,550 at Stifel
04/16/21 KeyBanc
Chipotle price target raised to $1,725 from $1,625 at KeyBanc
04/13/21 Wells Fargo
Chipotle price target raised to $1,800 from $1,775 at Wells Fargo
04/12/21
Fly Intel: Top five analyst upgrades
WHR Whirlpool
$234.84 /

-1.63 (-0.69%)

04/15/21 Raymond James
Raymond James says AHAM Q1 U.S. 'core 6' appliance wholesale shipments up 18%
04/07/21 JPMorgan
Whirlpool price target raised to $261 from $258 at JPMorgan
04/07/21 JPMorgan
JPMorgan lays out long and short homebuilding ideas into earnings
02/17/21 Raymond James
Raymond James sees bullish relative stock performance NT for Whirlpool
SAVE Spirit Airlines
$36.04 /

+1.36 (+3.92%)

04/15/21 Barclays
Spirit Airlines price target raised to $50 from $35 at Barclays
04/14/21
Fly Intel: Top five analyst upgrades
04/14/21 JPMorgan
JPMorgan double upgrades Spirit Airlines on 'material upside' potential
04/14/21 JPMorgan
Spirit Airlines upgraded to Overweight from Underweight at JPMorgan
CP Canadian Pacific
$355.40 /

+0.55 (+0.15%)

04/21/21 Scotiabank
Canadian Pacific price target lowered to C$480 from C$516 at Scotiabank
04/15/21
Fly Intel: Top five analyst upgrades
04/15/21 Barclays
Canadian Pacific upgraded to Overweight from Equal Weight at Barclays
04/09/21 Scotiabank
Canadian Pacific price target raised to C$516 from C$510 at Scotiabank
KMI Kinder Morgan
$16.70 /

+0.15 (+0.91%)

03/09/21
Fly Intel: Top five analyst downgrades
03/09/21 Bernstein
Kinder Morgan downgraded to Market Perform from Outperform at Bernstein
01/12/21
Fly Intel: Top five analyst downgrades
01/12/21 Barclays
Kinder Morgan downgraded to Equal Weight from Overweight at Barclays
DFS Discover
$98.44 /

+1.59 (+1.64%)

04/19/21
Fly Intel: Top five analyst downgrades
04/18/21 BMO Capital
Discover downgraded to Market Perform from Outperform at BMO Capital
04/16/21 Piper Sandler
Discover price target raised to $103 from $97 at Piper Sandler
04/08/21 Piper Sandler
Discover price target raised to $97 from $94 at Piper Sandler
SLM Sallie Mae
$19.55 /

+0.78 (+4.16%)

04/15/21 JPMorgan
Sallie Mae price target raised to $21 from $18 at JPMorgan
04/12/21 Barclays
Sallie Mae price target raised to $28 from $18 at Barclays
03/19/21 Jefferies
Sallie Mae price target raised to $23 from $19 at Jefferies
03/16/21 Citi
Sallie Mae price target raised to $20 from $16 at Citi
CLB Core Laboratories
$27.05 /

+0.79 (+3.01%)

01/11/21 Wolfe Research
Core Laboratories upgraded to Peer Perform from Underperform at Wolfe Research
12/18/20 JPMorgan
Core Laboratories downgraded to Underweight with $18 target at JPMorgan
12/18/20 JPMorgan
Core Laboratories downgraded to Underweight from Neutral at JPMorgan
12/15/20 Citi
Core Laboratories price target raised to $30 from $16 at Citi
UFPI UFP Industries
$78.18 /

+0.77 (+0.99%)

04/15/21 Wedbush
UFP Industries price target raised to $75 from $65 at Wedbush
03/22/21 DA Davidson
UFP Industries price target raised to $80 from $75 at DA Davidson
03/09/21 Stifel
UFP Industries resumed with a Buy at Stifel
03/03/21 BMO Capital
UFP Industries price target raised to $66 from $57 at BMO Capital
RHI Robert Half
$82.61 /

+1.235 (+1.52%)

03/01/21 Barclays
Robert Half price target raised to $85 from $42 at Barclays
03/01/21 Barclays
ManpowerGroup upgraded to Overweight from Underweight at Barclays
02/03/21 BofA
Robert Half upgraded to Buy from Neutral at BofA
02/03/21
Robert Half price target raised to $67 from $52 at Truist
CHDN Churchill Downs
$219.10 /

+8.16 (+3.87%)

04/06/21 Credit Suisse
Reports, contacts point to sports betting momentum in NY, Credit Suisse says
03/18/21 JPMorgan
Micro-betting market in U.S. 'could be substantial,' says JPMorgan
03/01/21 KeyBanc
Churchill Downs price target raised to $250 from $239 at KeyBanc
02/09/21 Morgan Stanley
Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds
STC Stewart
$56.38 /

+0.21 (+0.37%)

02/15/21 Keefe Bruyette
Stewart price target raised to $70 from $60 at Keefe Bruyette
10/23/20 Stephens
Stewart upgraded to Overweight from Equal Weight at Stephens
09/09/20 Keefe Bruyette
Stewart price target raised to $50 from $47 at Keefe Bruyette
07/27/20
Fly Intel: Top five analyst upgrades
EFX Equifax
$192.59 /

+0.355 (+0.18%)

03/31/21 Goldman Sachs
Equifax shares have near-term downside risk, says Goldman Sachs
03/11/21 Autonomous
Equifax initiated with an Outperform at Autonomous
01/29/21 Needham
TransUnion initiated with a Hold at Needham
01/08/21 Stephens
Stephens likes 'network effect' of Equifax buying Kount
XM Qualtrics
$33.80 /

+ (+0.00%)

04/12/21 BMO Capital
Qualtrics price target lowered to $38 from $45 at BMO Capital
04/09/21 Barclays
Qualtrics price target lowered to $35 from $39 at Barclays
03/17/21
Fly Intel: Top five analyst initiations
03/17/21 HSBC
Qualtrics initiated with a Hold at HSBC
XM Qualtrics
$33.80 /

+ (+0.00%)

WHR Whirlpool
$234.84 /

-1.63 (-0.69%)

UFPI UFP Industries
$78.18 /

+0.77 (+0.99%)

TDC Teradata
$39.89 /

+1.07 (+2.76%)

STC Stewart
$56.38 /

+0.21 (+0.37%)

SNBR Sleep Number
$124.88 /

+5.07 (+4.23%)

SLM Sallie Mae
$19.55 /

+0.78 (+4.16%)

SEIC SEI Investments
$63.04 /

+0.3 (+0.48%)

SAVE Spirit Airlines
$36.04 /

+1.36 (+3.92%)

RHI Robert Half
$82.61 /

+1.235 (+1.52%)

NTGR Netgear
$37.81 /

+0.31 (+0.83%)

NBSE NeuBase Therapeutics
$6.01 /

+0.19 (+3.26%)

KMI Kinder Morgan
$16.70 /

+0.15 (+0.91%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

EFX Equifax
$192.59 /

+0.355 (+0.18%)

DFS Discover
$98.44 /

+1.59 (+1.64%)

CP Canadian Pacific
$355.40 /

+0.55 (+0.15%)

CMG Chipotle
$1,507.85 /

-25.58 (-1.67%)

CLB Core Laboratories
$27.05 /

+0.79 (+3.01%)

CHDN Churchill Downs
$219.10 /

+8.16 (+3.87%)

CACI CACI
$255.88 /

-6 (-2.29%)

  • 22
    Apr
  • 22
    Apr
  • 13
    Aug
  • 08
    May
  • 28
    Apr
  • 28
    Jan
XM Qualtrics
$33.80 /

+ (+0.00%)

SAVE Spirit Airlines
$36.04 /

+1.36 (+3.92%)

NTGR Netgear
$37.81 /

+0.31 (+0.83%)

KMI Kinder Morgan
$16.70 /

+0.15 (+0.91%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

CMG Chipotle
$1,507.85 /

-25.58 (-1.67%)

CHDN Churchill Downs
$219.10 /

+8.16 (+3.87%)

XM Qualtrics
$33.80 /

+ (+0.00%)

WHR Whirlpool
$234.84 /

-1.63 (-0.69%)

TDC Teradata
$39.89 /

+1.07 (+2.76%)

SNBR Sleep Number
$124.88 /

+5.07 (+4.23%)

SLM Sallie Mae
$19.55 /

+0.78 (+4.16%)

SEIC SEI Investments
$63.04 /

+0.3 (+0.48%)

SAVE Spirit Airlines
$36.04 /

+1.36 (+3.92%)

RHI Robert Half
$82.61 /

+1.235 (+1.52%)

NTGR Netgear
$37.81 /

+0.31 (+0.83%)

NBSE NeuBase Therapeutics
$6.01 /

+0.19 (+3.26%)

KMI Kinder Morgan
$16.70 /

+0.15 (+0.91%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

EFX Equifax
$192.59 /

+0.355 (+0.18%)

DFS Discover
$98.44 /

+1.59 (+1.64%)

CP Canadian Pacific
$355.40 /

+0.55 (+0.15%)

CMG Chipotle
$1,507.85 /

-25.58 (-1.67%)

CHDN Churchill Downs
$219.10 /

+8.16 (+3.87%)

XM Qualtrics
$33.80 /

+ (+0.00%)

TDC Teradata
$39.89 /

+1.07 (+2.76%)

SLM Sallie Mae
$19.55 /

+0.78 (+4.16%)

SAVE Spirit Airlines
$36.04 /

+1.36 (+3.92%)

RHI Robert Half
$82.61 /

+1.235 (+1.52%)

KMI Kinder Morgan
$16.70 /

+0.15 (+0.91%)

EOLS Evolus
$11.69 /

+1.16 (+11.02%)

EFX Equifax
$192.59 /

+0.355 (+0.18%)

DFS Discover
$98.44 /

+1.59 (+1.64%)

CMG Chipotle
$1,507.85 /

-25.58 (-1.67%)

Syndicate
Evolus files to sell common stock, no amount given » 16:02
04/21/21
04/21
16:02
04/21/21
16:02
EOLS

Evolus

$11.71 /

+1.18 (+11.21%)

SVB Leerink, Stifel and…

SVB Leerink, Stifel and Cantor are acting as joint bookrunning managers for the offering.

ShowHide Related Items >><<
EOLS Evolus
$11.71 /

+1.18 (+11.21%)

EOLS Evolus
$11.71 /

+1.18 (+11.21%)

04/08/21 H.C. Wainwright
Evolus price target raised to $22 from $20 at H.C. Wainwright
03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
EOLS Evolus
$11.71 /

+1.18 (+11.21%)

EOLS Evolus
$11.71 /

+1.18 (+11.21%)

EOLS Evolus
$11.71 /

+1.18 (+11.21%)

EOLS Evolus
$11.71 /

+1.18 (+11.21%)

Over a month ago
Recommendations
Evolus price target raised to $22 from $20 at H.C. Wainwright » 06:07
04/08/21
04/08
06:07
04/08/21
06:07
EOLS

Evolus

$13.91 /

+0.72 (+5.46%)

H.C. Wainwright analyst…

H.C. Wainwright analyst Douglas Tsao raised the firm's price target on Evolus to $22 from $20 and reiterates a Buy rating on the shares. The analyst expects sales of Jeuveau to get a lift in Q2 due to additional discretionary income from the latest stimulus payment as well as a return of in-person socialization brought on increased vaccine eligibility and a relaxing of social distancing restriction.

ShowHide Related Items >><<
EOLS Evolus
$13.91 /

+0.72 (+5.46%)

EOLS Evolus
$13.91 /

+0.72 (+5.46%)

03/30/21 Mizuho
Evolus price target raised to $15 from $9 at Mizuho
03/24/21 H.C. Wainwright
Evolus price target raised to $20 from $18 at H.C. Wainwright
02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
02/24/21 Truist
Evolus downgraded to Hold from Buy at Truist
EOLS Evolus
$13.91 /

+0.72 (+5.46%)

EOLS Evolus
$13.91 /

+0.72 (+5.46%)

EOLS Evolus
$13.91 /

+0.72 (+5.46%)

EOLS Evolus
$13.91 /

+0.72 (+5.46%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.